← All themes

Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 204 Korean stocks listed on KOSPI and KOSDAQ, worth ₩219T in total. On Oct 27, 2026 the group moved down 2.05% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Key facts

Stocks
204
Total market value
₩219T
Day's move
−2.05%
As of
Oct 27, 2026
Largest members
Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 3Q 2026

Reporting season · reports due by Nov 14

9 of 208 reportedOperating profit up vs a year ago: 6 of 7
Revenue+19.1%
Operating profit+40.4%
Net profit+27.9%

Combined, for the companies that have reported, vs the same quarter a year ago

CompanyReportedRevenuevs a year agoOperating profitvs a year agovs last quarterOp. margin
CelltrionOct 12Preliminary₩1.5T+45.8%₩510B+69.2%+12.9%34.0%29.3%
Samsung Epis HoldingsOct 28Preliminary₩442B+0.3%₩133B+2.8%+125.8%30.0%29.3%
YuhanOct 28Preliminary₩586B+2.8%₩35B+57.8%−48.0%5.9%3.9%
Hanmi PharmOct 27Preliminary₩377B+4.2%₩38B−31.3%−71.2%10.0%15.2%
ST PharmOct 27Preliminary₩98B+19.1%₩16B+6.6%−14.3%16.1%18.0%
Bukwang Pharmaceutical INDOct 23Preliminary₩58B+21.2%₩2.2B+120.7%+53.3%3.7%2.0%
Dong-A STOct 27Preliminary₩207B−4.4%₩21B+52.9%+239.9%10.4%6.5%
T&R BiofabOct 19Preliminary₩8.9B+28.1%————
ShaperonOct 1Preliminary₩4.7B+2,683.4%————
Samsung BiologicsExpected around Oct 28
Hanmi ScienceExpected around Oct 29
Hanall BiopharmaExpected around Oct 29
Onconic TherapeuticsExpected around Oct 30
BioneercorporationExpected around Oct 31
AbionExpected around Oct 31
SK BioscienceExpected around Nov 3
GC BiopharmaExpected around Nov 3
Chong Kun Dang PharmaceuticalExpected around Nov 3
JW PharmaceuticalExpected around Nov 3
GC CellExpected around Nov 3
Choong ANG Vaccine LaboratoryExpected around Nov 3
HugelExpected around Nov 4
SK biopharmaceuticalsExpected around Nov 5
JW ShinyakExpected around Nov 5
IL Dong PharmaceuticalExpected around Nov 6
ISU AbxisExpected around Nov 6
Cell BiotechExpected around Nov 6
SeegeneExpected around Nov 7
Daewoong PharmaExpected around Nov 7
NeoImmuneTechExpected around Nov 7
QuadMedicineExpected around Nov 7
Medy-ToxExpected around Nov 10
AbClonExpected around Nov 10
EuBiologicsExpected around Nov 10
Vivozon PharmaceuticalExpected around Nov 10
Eye GeneExpected around Nov 10
Daesung Microbiological LabsExpected around Nov 10
PharmaResearchExpected around Nov 11
ABL BioExpected around Nov 11
RznomicsExpected around Nov 11
Pharos iBioExpected around Nov 11
OlipassExpected around Nov 11
OSCOTECIncExpected around Nov 12
MedPactoExpected around Nov 12
CTC BioExpected around Nov 12
GencurixExpected around Nov 12
LinkgenesisExpected around Nov 12
ChabiotechExpected around Nov 13
G2GBIOExpected around Nov 13
PharmicellExpected around Nov 13
CurocellExpected around Nov 13
AprilBioExpected around Nov 13
DuChemBioExpected around Nov 13
3billionExpected around Nov 13
Kangstem BiotechExpected around Nov 13
GenexineExpected around Nov 13
ViGenCellExpected around Nov 13
AribiolabExpected around Nov 13
DreamCISExpected around Nov 13
DongKook Life ScienceExpected around Nov 13
SunBioExpected around Nov 13
Pangen BiotechExpected around Nov 13
CytogenExpected around Nov 13
KoBioLabsExpected around Nov 13
WonbiogenExpected around Nov 13
EutilexExpected around Nov 13
BiotoxtechExpected around Nov 13
NGeneBioExpected around Nov 13
AlteogenExpected around Nov 14
HLBExpected around Nov 14
PeptronExpected around Nov 14
VoronoiExpected around Nov 14
OliX PharmaceuticalsExpected around Nov 14
D&D PharmatechExpected around Nov 14
CaregenExpected around Nov 14
Mezzion PharmaExpected around Nov 14
NaturecellExpected around Nov 14
Kolon TissueGeneExpected around Nov 14
Curiox BiosystemsExpected around Nov 14
QurientExpected around Nov 14
JS LinkExpected around Nov 14
L&C BioExpected around Nov 14
Hyundai BioscienceExpected around Nov 14
ProteinaExpected around Nov 14
GI InnovationExpected around Nov 14
Shinpoong PharmaceuticalExpected around Nov 14
GCExpected around Nov 14
GemVax & KAELExpected around Nov 14
HLB Life ScienceExpected around Nov 14
Penetrium BioscienceExpected around Nov 14
Orum TherapeuticsExpected around Nov 14
MedipostcoExpected around Nov 14
SillaJenExpected around Nov 14
ToolGenExpected around Nov 14
NKGen Biotech KoreaExpected around Nov 14
FutureChemExpected around Nov 14
ImmuneOncia TherapeuticsExpected around Nov 14
Q AIDExpected around Nov 14
S.BiomedicsExpected around Nov 14
HLB TherapeuticsExpected around Nov 14
GenomictreeExpected around Nov 14
IntoCellExpected around Nov 14
JetemaExpected around Nov 14
BioPlusExpected around Nov 14
Genome&CompanyExpected around Nov 14
BinexExpected around Nov 14
GC GenomeExpected around Nov 14
curacleExpected around Nov 14
HelixmithExpected around Nov 14
Aptabio TherapeuticsExpected around Nov 14
BNC KoreaExpected around Nov 14
Eone Diagnomics Genome CenterExpected around Nov 14
Kolon Life ScienceExpected around Nov 14
Y-BiologicsExpected around Nov 14
Bio SolutionExpected around Nov 14
CellbionExpected around Nov 14
Aribio HoldingsExpected around Nov 14
AnterogenExpected around Nov 14
MacrogenExpected around Nov 14
TiumBioExpected around Nov 14
Keeps BiopharmaExpected around Nov 14
HLB bioStepExpected around Nov 14
CelemicsExpected around Nov 14
MetabiomedExpected around Nov 14
AstaExpected around Nov 14
CHA AI HealthkareExpected around Nov 14
iNtRON BiotechnologyExpected around Nov 14
HLB GlobalExpected around Nov 14
Vaxcell-Bio TherapeuticsExpected around Nov 14
AminologicsExpected around Nov 14
CorestemchemonExpected around Nov 14
Enzychem LifesciencesExpected around Nov 14
SCL ScienceExpected around Nov 14
Theragen EtexExpected around Nov 14
Polaris AI PharmaExpected around Nov 14
HLB GenexExpected around Nov 14
Choolip & SciencesExpected around Nov 14
SugentechExpected around Nov 14
Naturalendo TechExpected around Nov 14
AmicogenExpected around Nov 14
OptipharmExpected around Nov 14
CellidExpected around Nov 14
PharmGen ScienceExpected around Nov 14
AdbiotechExpected around Nov 14
HLB PanageneExpected around Nov 14
Tego ScienceExpected around Nov 14
GeninusExpected around Nov 14
ENCellExpected around Nov 14
AprogenExpected around Nov 14
GeneOne Life ScienceExpected around Nov 14
CJ BioscienceExpected around Nov 14
RPbioExpected around Nov 14
QuratisExpected around Nov 14
OncocrossExpected around Nov 14
HLB PepExpected around Nov 14
OrganoidsciencesExpected around Nov 14
OrientbioExpected around Nov 14
IMBdxExpected around Nov 14
Kainos MedicineExpected around Nov 14
Kolmar BioTechExpected around Nov 14
Aligned GeneticsExpected around Nov 14
SeouLin BioscienceExpected around Nov 14
HassExpected around Nov 14
GenolutionExpected around Nov 14
SLSBio(Specialty Lab Solution Bio)Expected around Nov 14
GenematrixExpected around Nov 14
LabGenomicsExpected around Nov 14
Dt&CroExpected around Nov 14
C&R ResearchExpected around Nov 14
GFC Life ScienceExpected around Nov 14
EnbiocoExpected around Nov 14
MFCExpected around Nov 14
WooGene B&GcoExpected around Nov 14
Xcell TherapeuticsExpected around Nov 14
PCLExpected around Nov 14
Kbio LabsExpected around Nov 14
PeopleBioExpected around Nov 14
CelestraExpected around Nov 14
From BioExpected around Nov 14
BioInfraExpected around Nov 14
208340Expected around Nov 14
PhionxExpected around Nov 27
HEM PharmaExpected around Nov 28
Aimed BioNot yet
Ingenia TherapeuticsNot yet
BioNoteNot yet
Samyang BiopharmNot yet
Kanaph TherapeuticsNot yet
Pharmaresearch BioNot yet
Ensol BiosciencesNot yet
InventeraNot yet
ImgtNot yet
HL GenomicsNot yet
Epi BiotechNot yet
NovMetaPharmaNot yet
ProGenNot yet
Plumbline Life SciencesNot yet
Moogene MediNot yet
CurachemNot yet
Invites BiocoreNot yet
Median DiagnosticsNot yet
CronexNot yet
Medizen HumancareNot yet
BioInfra Life ScienceNot yet
283100Not yet
072520Not yet
258540Not yet
341170Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 27, 2026
Above 20-day average
14.1%
Above 60-day average
22.4%
RSI above 70
0.6%
RSI below 30
7.1%
52-week highs
0
52-week lows
12

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

1 bullish, 1 neutral, 6 bearish

Technical read

The Biotech (new drugs) theme covers 170 member stocks, and only 14.1% of them are trading above their 20-day averages while 22.4% are above their 60-day averages. Breadth is weak, with 12 members at 52-week lows and none at 52-week highs, and 7.1% of members sit in RSI oversold territory against 0.6% in overbought territory. The equal-weighted member index is below its cloud with an RSI of 39.5, and both its short-term and medium-term readings are labeled bearish.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

  • MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
  • MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
  • MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK ReitSK hynixSK NetworksSK DiscoverySKCSK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Biotech (new drugs)

−4.48%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

204 companies · 32 up · 17 flat · 155 down

Traded value
₩690B
Value vs 20-day average
0.74×
Top gainer
Y-Biologics
+25.46%
Largest company
Samsung Biologics
₩64T

Companies in this theme

CompanyPriceWeeklyTraded valueMarket capNPS
Samsung Biologics207940 · KOSPI
₩1,374,000−1.22%₩124B₩64T6.88%
Celltrion068270 · KOSPI
₩188,600−4.46%₩82B₩44T7.28%
Alteogen196170 · KOSDAQ
₩218,500−5.41%₩52B₩15T2.68%
Samsung Epis Holdings0126Z0 · KOSPI
₩312,000−5.17%₩7.8B₩7.8T5.70%
Yuhan000100 · KOSPI
₩80,000−7.19%₩16B₩5.9T6.83%
SK biopharmaceuticals326030 · KOSPI
₩74,900+0.54%₩7B₩5.9T6.00%
HLB028300 · KOSDAQ
₩39,900−7.21%₩19B₩5.3T1.16%
Hanmi Pharm128940 · KOSPI
₩350,500−7.40%₩26B₩4.5T9.61%
Hanmi Science008930 · KOSPI
₩41,400−6.02%₩5B₩2.8T6.27%
SK Bioscience302440 · KOSPI
₩31,750−11.31%₩2.4B₩2.5T5.50%
PharmaResearch214450 · KOSDAQ
₩231,500−12.97%₩15B₩2.4T7.14%
ABL Bio298380 · KOSDAQ
₩40,850−8.61%₩10B₩2.3T4.02%
Hugel145020 · KOSDAQ
₩179,400−2.61%₩7.3B₩2.2T2.29%
Peptron087010 · KOSDAQ
₩95,600−5.53%₩16B₩2.2T1.63%
Voronoi310210 · KOSDAQ
₩118,800−9.93%₩8.9B₩2.2T2.78%
OliX Pharmaceuticals226950 · KOSDAQ
₩90,600−7.17%₩24B₩2.1T5.04%
Hanall Biopharma009420 · KOSPI
₩38,250−7.94%₩7.2B₩2T10.56%
D&D Pharmatech347850 · KOSDAQ
₩40,800+0.49%₩14B₩1.9T1.75%
Caregen214370 · KOSDAQ
₩33,300−15.80%₩2.6B₩1.8T0.65%
ST Pharm237690 · KOSDAQ
₩80,400−12.80%₩21B₩1.7T5.77%
Mezzion Pharma140410 · KOSDAQ
₩53,900−8.18%₩7.4B₩1.7T0.50%
Seegene096530 · KOSDAQ
₩32,800−11.11%₩8.7B₩1.5T0.64%
GC Biopharma006280 · KOSPI
₩129,100−2.71%₩2.1B₩1.5T6.68%
Naturecell007390 · KOSDAQ
₩22,300−3.88%₩4.4B₩1.4T0.44%
OSCOTECInc039200 · KOSDAQ
₩35,900−4.27%₩4.5B₩1.4T3.87%
Aimed Bio0009K0 · KOSDAQ
₩20,550−8.87%₩4.8B₩1.3T0.03%
Kolon TissueGene950160 · KOSDAQ
₩14,760−4.53%₩3.2B₩1.3T0.57%
Ingenia Therapeutics950260 · KOSDAQ
₩23,250+5.44%₩6.6B₩1.1T—
Daewoong Pharma069620 · KOSPI
₩99,100−5.53%₩2.2B₩1.1T10.30%
Curiox Biosystems445680 · KOSDAQ
₩62,300+15.37%₩8.2B₩1.1T1.25%
₩61,300−8.37%₩1.5B₩846B6.34%
Qurient115180 · KOSDAQ
₩18,440−7.80%₩2.6B₩692B3.88%
JS Link127120 · KOSDAQ
₩18,160−2.37%₩2.9B₩680B5.05%
Chabiotech085660 · KOSDAQ
₩7,030−8.22%₩1.4B₩654B0.31%
G2GBIO456160 · KOSDAQ
₩39,150+5.81%₩47B₩651B2.41%
L&C Bio290650 · KOSDAQ
₩23,800−25.17%₩9B₩642B1.28%
Rznomics476830 · KOSDAQ
₩22,550−3.63%₩5.1B₩633B3.96%
Pharmicell005690 · KOSPI
₩9,800−7.02%₩2.9B₩588B2.38%
Onconic Therapeutics476060 · KOSDAQ
₩12,770−6.03%₩1.6B₩580B—
JW Pharmaceutical001060 · KOSPI
₩23,150−7.58%₩591M₩569B2.44%
Hyundai Bioscience048410 · KOSDAQ
₩5,820−13.00%₩7.8B₩562B0.37%
Proteina468530 · KOSDAQ
₩48,950+14.10%₩6.7B₩544B3.78%
Medy-Tox086900 · KOSDAQ
₩67,500−3.30%₩913M₩493B1.44%
BioNote377740 · KOSPI
₩4,555−0.11%₩183M₩464B0.81%
GI Innovation358570 · KOSDAQ
₩7,030−14.27%₩2.5B₩454B4.07%
₩8,350−9.44%₩1.3B₩438B0.39%
GC005250 · KOSPI
₩9,030−5.74%₩827M₩425B5.94%
AbClon174900 · KOSDAQ
₩21,100−6.43%₩2.7B₩421B3.57%
GemVax & KAEL082270 · KOSDAQ
₩9,010−9.36%₩1.1B₩410B2.55%
HLB Life Science067630 · KOSDAQ
₩3,355−11.36%₩565M₩409B0.07%
Penetrium Bioscience187660 · KOSDAQ
₩6,350+8.55%₩9.8B₩406B—
IL Dong Pharmaceutical249420 · KOSPI
₩12,650−5.81%₩915M₩400B2.30%
Curocell372320 · KOSDAQ
₩24,400+1.46%₩711M₩372B0.46%
₩3,755−4.09%₩1.3B₩370B0.68%
Orum Therapeutics475830 · KOSDAQ
₩16,070−1.05%₩2.2B₩350B0.09%
AprilBio397030 · KOSDAQ
₩12,340−6.52%₩1.1B₩340B0.95%
Dong-A ST170900 · KOSPI
₩34,900−3.32%₩1.2B₩340B4.78%
Medipostco078160 · KOSDAQ
₩8,490−5.35%₩298M₩333B1.55%
Samyang Biopharm0120G0 · KOSPI
₩42,000−4.87%₩1B₩312B1.73%
SillaJen215600 · KOSDAQ
₩2,130−4.05%₩1.2B₩295B0.09%
ToolGen199800 · KOSDAQ
₩28,050−3.11%₩271M₩274B0.43%
EuBiologics206650 · KOSDAQ
₩7,500−4.70%₩848M₩273B0.17%
NKGen Biotech Korea182400 · KOSDAQ
₩3,6700.00%₩0₩265B—
FutureChem220100 · KOSDAQ
₩8,420+19.94%₩4.4B₩261B0.76%
ImmuneOncia Therapeutics424870 · KOSDAQ
₩2,830−7.36%₩637M₩259B—
Q AID377460 · KOSDAQ
₩4,0800.00%₩0₩253B—
S.Biomedics304360 · KOSDAQ
₩20,200−6.05%₩163M₩252B—
HLB Therapeutics115450 · KOSDAQ
₩2,650−2.21%₩1.1B₩251B0.10%
Genomictree228760 · KOSDAQ
₩9,730+1.14%₩521M₩242B0.51%
IntoCell287840 · KOSDAQ
₩15,980−5.78%₩366M₩240B1.04%
Jetema216080 · KOSDAQ
₩6,030+0.33%₩672M₩225B0.01%
BioPlus099430 · KOSDAQ
₩3,320−8.03%₩434M₩205B0.42%
GC Cell144510 · KOSDAQ
₩12,950−5.13%₩171M₩205B0.06%
Genome&Company314130 · KOSDAQ
₩3,900−7.47%₩898M₩204B0.24%
HEM Pharma376270 · KOSDAQ
₩28,250−6.30%₩181M₩204B—
DuChemBio176750 · KOSDAQ
₩7,040−21.60%₩2.3B₩201B0.04%
Binex053030 · KOSDAQ
₩6,070−0.82%₩465M₩198B2.17%
GC Genome340450 · KOSDAQ
₩8,340−18.63%₩6B₩197B—
Bioneercorporation064550 · KOSDAQ
₩7,070−8.89%₩878M₩182B0.10%
Vivozon Pharmaceutical082800 · KOSDAQ
₩2,960−4.82%₩215M₩180B—
3billion394800 · KOSDAQ
₩5,580+5.68%₩4.4B₩178B4.02%
curacle365270 · KOSDAQ
₩7,930−12.18%₩468M₩176B0.50%
Helixmith084990 · KOSDAQ
₩3,810−4.63%₩664M₩176B0.12%
Kangstem Biotech217730 · KOSDAQ
₩1,865−5.57%₩397M₩175B0.10%
Aptabio Therapeutics293780 · KOSDAQ
₩6,030−12.61%₩376M₩169B0.05%
BNC Korea256840 · KOSDAQ
₩2,475−13.61%₩1.1B₩169B—
₩7410.00%₩0₩167B—
Kolon Life Science102940 · KOSDAQ
₩12,760−4.85%₩596M₩167B0.50%
Y-Biologics338840 · KOSDAQ
₩10,200+25.46%₩834M₩157B0.17%
Bio Solution086820 · KOSDAQ
₩5,650−4.56%₩180M₩146B0.15%
Cellbion308430 · KOSDAQ
₩11,320−10.51%₩302M₩146B—
Aribio Holdings290690 · KOSDAQ
₩2,735−6.34%₩819M₩145B—
ISU Abxis086890 · KOSDAQ
₩3,535−7.22%₩221M₩144B0.20%
Cell Biotech049960 · KOSDAQ
₩14,910−2.29%₩61M₩140B0.00%
Anterogen065660 · KOSDAQ
₩13,980−2.58%₩281M₩140B0.30%
JW Shinyak067290 · KOSDAQ
₩2,360−6.72%₩2B₩132B—
Kanaph Therapeutics0082N0 · KOSDAQ
₩9,810−6.93%₩775M₩130B—
Pharmaresearch Bio217950 · KONEX
₩29,250+0.34%₩410,050₩122B—
Macrogen038290 · KOSDAQ
₩11,050−4.66%₩102M₩120B4.56%
Ensol Biosciences140610 · KONEX
₩8,320−8.17%₩18M₩120B—
TiumBio321550 · KOSDAQ
₩3,905−5.79%₩530M₩117B0.31%
Keeps Biopharma256940 · KOSDAQ
₩5,490−5.18%₩550M₩110B—
HLB bioStep278650 · KOSDAQ
₩6,280+4.84%₩2.6B₩109B—
Genexine095700 · KOSDAQ
₩2,325−10.58%₩270M₩106B0.15%
ViGenCell308080 · KOSDAQ
₩5,070−5.23%₩419M₩104B0.59%
MedPacto235980 · KOSDAQ
₩3,015−11.06%₩186M₩103B2.96%
Celemics331920 · KOSDAQ
₩9,220−6.01%₩543M₩103B—
Metabiomed059210 · KOSDAQ
₩3,660−3.94%₩164M₩99B—
Asta246720 · KOSDAQ
₩6,0700.00%₩0₩99B—
Aribiolab261780 · KOSDAQ
₩3,400−11.23%₩1.3B₩98B—
CHA AI Healthkare025620 · KOSPI
₩5,350−0.56%₩36M₩97B0.01%
DreamCIS223250 · KOSDAQ
₩3,955+5.33%₩1.8B₩97B—
iNtRON Biotechnology048530 · KOSDAQ
₩3,050+1.67%₩974M₩94B1.38%
HLB Global003580 · KOSPI
₩1,826−10.05%₩520M₩93B0.29%
T&R Biofab246710 · KOSDAQ
₩1,940−3.96%₩153M₩92B0.95%
Vaxcell-Bio Therapeutics323990 · KOSDAQ
₩3,965−6.92%₩177M₩92B0.07%
Aminologics074430 · KOSDAQ
₩1,000−1.48%₩76M₩89B—
Corestemchemon166480 · KOSDAQ
₩1,664−9.81%₩141M₩88B0.02%
Enzychem Lifesciences183490 · KOSDAQ
₩9900.00%₩0₩84B0.30%
₩8,780−1.79%₩28M₩81B—
SCL Science246960 · KOSDAQ
₩2,295+1.55%₩241M₩80B—
Eye Gene185490 · KOSDAQ
₩1,749−9.66%₩94M₩76B2.40%
Pharos iBio388870 · KOSDAQ
₩5,810−5.83%₩120M₩75B—
Yuhan Pref.000105 · KOSPI
₩65,200−8.04%₩75M₩75B—
Theragen Etex066700 · KOSDAQ
₩2,025+0.25%₩59M₩74B0.40%
Polaris AI Pharma041910 · KOSDAQ
₩5,530−2.98%₩97M₩73B—
DongKook Life Science303810 · KOSDAQ
₩2,280−9.52%₩323M₩73B—
HLB Genex187420 · KOSDAQ
₩2,230−8.61%₩217M₩73B—
Choolip & Sciences291650 · KOSDAQ
₩2,385−7.56%₩163M₩73B—
SunBio067370 · KOSDAQ
₩5,620−3.44%₩47M₩69B—
Sugentech253840 · KOSDAQ
₩4,080−6.42%₩137M₩68B—
Inventera0007J0 · KOSDAQ
₩8,630−6.70%₩150M₩68B—
Naturalendo Tech168330 · KOSDAQ
₩2,090−1.65%₩12M₩66B0.10%
CTC Bio060590 · KOSDAQ
₩2,720−4.73%₩89M₩66B—
Amicogen092040 · KOSDAQ
₩915−8.04%₩182M₩65B0.37%
Optipharm153710 · KOSDAQ
₩4,350−2.25%₩21M₩64B0.44%
Cellid299660 · KOSDAQ
₩2,125−8.80%₩207M₩63B0.02%
PharmGen Science004720 · KOSPI
₩2,750−1.08%₩16M₩62B0.08%
Pangen Biotech222110 · KOSDAQ
₩4,580−6.24%₩19M₩62B—
Adbiotech179530 · KOSDAQ
₩1,983+0.86%₩60M₩62B—
Abion203400 · KOSDAQ
₩3,3800.00%₩0₩61B0.98%
HLB Panagene046210 · KOSDAQ
₩1,286−12.75%₩155M₩59B—
NeoImmuneTech950220 · KOSDAQ
₩1,670−2.62%₩260M₩57B—
Imgt456570 · KONEX
₩10,800−9.92%₩2.8M₩57B—
Cytogen217330 · KOSDAQ
₩2,450−8.07%₩121M₩57B—
Tego Science191420 · KOSDAQ
₩6,960+1.75%₩22M₩56B—
HL Genomics0156T0 · KOSDAQ
₩7,120−6.56%₩101M₩55B—
KoBioLabs348150 · KOSDAQ
₩2,750−3.34%₩48M₩53B—
Geninus389030 · KOSDAQ
₩1,335−15.51%₩630M₩53B—
Epi Biotech446440 · KONEX
₩21,950+9.75%₩742,950₩51B—
ENCell456070 · KOSDAQ
₩4,590−8.20%₩152M₩51B—
Aprogen007460 · KOSPI
₩1,914−2.00%₩74M₩49B0.76%
GeneOne Life Science011000 · KOSPI
₩2,6700.00%₩0₩49B0.19%
CJ Bioscience311690 · KOSDAQ
₩3,640−2.15%₩23M₩48B—
QuadMedicine464490 · KOSDAQ
₩4,090−8.91%₩116M₩47B—
Gencurix229000 · KOSDAQ
₩1,9570.00%₩0₩46B0.81%
RPbio314140 · KOSDAQ
₩5,270−2.23%₩34M₩46B—
NovMetaPharma229500 · KONEX
₩3,385−1.88%₩4.9M₩44B—
Quratis348080 · KOSDAQ
₩3,400+5.59%₩62M₩44B—
Oncocross382150 · KOSDAQ
₩3,110−2.81%₩99M₩41B—
Wonbiogen307280 · KOSDAQ
₩5,700−1.38%₩23M₩40B—
HLB Pep196300 · KOSDAQ
₩4,145−3.27%₩57M₩39B—
Organoidsciences476040 · KOSDAQ
₩5,850−7.14%₩94M₩39B1.38%
Orientbio002630 · KOSPI
₩1,297−12.13%₩63M₩38B0.06%
IMBdx461030 · KOSDAQ
₩2,510−5.46%₩29M₩36B0.31%
Kainos Medicine284620 · KOSDAQ
₩1,0870.00%₩0₩36B—
Kolmar BioTech215380 · KOSDAQ
₩2,100−4.11%₩50M₩35B—
Eutilex263050 · KOSDAQ
₩9590.00%₩0₩35B0.74%
Aligned Genetics238120 · KOSDAQ
₩2,435−4.32%₩42M₩35B—
SeouLin Bioscience038070 · KOSDAQ
₩3,625−6.33%₩19M₩34B—
Hass450330 · KOSDAQ
₩4,095−11.94%₩31M₩34B—
Biotoxtech086040 · KOSDAQ
₩2,080+2.46%₩3.6M₩33B—
Genolution225220 · KOSDAQ
₩1,711+15.61%₩46M₩33B—
Linkgenesis219420 · KOSDAQ
₩2,800−8.94%₩41M₩32B—
ProGen296160 · KONEX
₩2,060−1.44%₩15M₩32B—
₩1,9690.00%₩0₩30B—
Genematrix109820 · KOSDAQ
₩1,450−3.97%₩38M₩30B—
LabGenomics084650 · KOSDAQ
₩1,850−21.61%₩151M₩27B0.58%
Dt&Cro383930 · KOSDAQ
₩2,030−16.29%₩93M₩26B—
C&R Research359090 · KOSDAQ
₩2,175−4.19%₩4.9M₩25B—
GFC Life Science388610 · KOSDAQ
₩4,545−4.11%₩43M₩24B—
Shaperon378800 · KOSDAQ
₩2,345+3.30%₩85M₩22B—
Enbioco352940 · KOSDAQ
₩1,931+0.52%₩7.9M₩21B—
₩5,490−4.02%₩19M₩21B—
MFC432980 · KOSDAQ
₩2,395−3.04%₩6.3M₩21B—
WooGene B&Gco018620 · KOSDAQ
₩2,825+8.65%₩93M₩20B—
₩4,6350.00%₩0₩19B—
Moogene Medi322970 · KONEX
₩1,820+0.55%₩173,214₩18B—
Xcell Therapeutics373110 · KOSDAQ
₩1,009−4.72%₩16M₩17B—
PCL241820 · KOSDAQ
₩6,0400.00%₩0₩17B—
Kbio Labs038530 · KOSDAQ
₩3,065−7.54%₩42M₩16B—
PeopleBio304840 · KOSDAQ
₩5610.00%₩0₩14B—
Celestra352770 · KOSDAQ
₩5,2500.00%₩0₩14B—
Olipass244460 · KOSDAQ
₩1,6510.00%₩0₩13B—
Curachem456190 · KONEX
₩7,2100.00%₩0₩13B—
NGeneBio354200 · KOSDAQ
₩681−22.44%₩223M₩11B—
From Bio377220 · KOSDAQ
₩1,929−21.90%₩484M₩11B—
Invites Biocore216400 · KONEX
₩1,399+0.72%₩230,190₩11B—
Median Diagnostics233250 · KONEX
₩4,800−2.04%₩4,800₩8.4B—
BioInfra199730 · KOSDAQ
₩1,601−33.29%₩379M₩7.8B—
Phionx900100 · KOSDAQ
₩1,350+23.18%₩250M₩7.1B—
Cronex215570 · KONEX
₩685+14.36%₩65,785₩4.6B—
Medizen Humancare236340 · KONEX
₩1,300−18.75%₩541,800₩4B—
BioInfra Life Science266470 · KONEX
₩95−6.86%₩379,876₩2.6B—

Source: KRX statistical information